ASSEMBLY BIOSCIENCES INC
ASMBLatest QuantConomy context for ASMB: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
17
Asset profile
ASSEMBLY BIOSCIENCES INC
QuantConomy has a structured record for ASMB. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ASMB
- Name
- ASSEMBLY BIOSCIENCES INC
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq openfigi
Latest signal rows
Recent signals for ASMB
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| executive change | neutral | 85 | Jun 5, 08:05 PM | ASMB filed 8-K: Director or Officer Changes, Shareholder Vote Results - 1 material event - [very strong neutral signal] |
| large sale | neutral | 35 | May 28, 12:56 AM | GILEAD SCIENCES, INC. was granted ASMB shares ($12.50M) - 471698 shares - [very weak neutral signal] |
| material agreement | bullish | 85 | May 26, 08:15 PM | ASMB filed 8-K: Material Definitive Agreement, Other Events - 2 material events - [very strong bullish signal] |
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ASMB | NASDAQ | fmp | Assembly Biosciences, Inc. |
| ASMB | NASDAQ | alphavantage | Assembly Biosciences Inc |
| ASMB | NASDAQ | alpaca | Assembly Biosciences, Inc. Common Stock |
Recent insider transactions
Buys, last 90d
0
Sells, last 90d
0
Rows
17
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | ALTIG ANTHONY E | Director | grant | 8,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Johnson-Pratt Lisa | Director | grant | 8,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | McHutchison John G | Director | grant | 8,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Houghton Michael | Director | grant | 8,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Mahony Susan | Director | grant | 8,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Consylman Gina | Director | grant | 8,000 | — | — | 4 on EDGAR |
| May 26, 2026 | GILEAD SCIENCES, INC. | Insider | grant | 471,698 | $26.50 | $12,499,997 | 4 on EDGAR |
| Mar 29, 2026 | Okazaki Jason A | CEO and President | grant | 94,250 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | White Nicole S | Chief Manufacturing Officer | grant | 14,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | White Nicole S | Chief Manufacturing Officer | grant | 26,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Delaney William E IV | Chief Scientific Officer | grant | 14,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Bjorkquist Jeanette M | PFO and PAO | grant | 6,500 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Delaney William E IV | Chief Scientific Officer | grant | 26,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Bjorkquist Jeanette M | PFO and PAO | grant | 3,500 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Okazaki Jason A | CEO and President | grant | 50,750 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Gaggar Anuj | Chief Medical Officer | grant | 26,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 29, 2026 | Gaggar Anuj | Chief Medical Officer | grant | 14,000 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Get the data
Query ASMB context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access